Proteomic Startup CS-Keys Attracts VC Seed Funding

Indianapolis-based CS-Keys received an investment from Triathlon Medical Ventures, the second investment CS has received since its creation in 2005, the company said this week.

The amount of the investment was not disclosed.

CS-Keys will use the funds to continue research and development of cancer-specific biomarkers and for marketing and regulatory strategies of the company.

Earlier this year, CS received a $285,000 investment from the Indiana Seed Fund.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" pseudogenes to help stave off cancer, according to the New York Times.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.